» Articles » PMID: 24992279

Tumour Size over 3 Cm Predicts Poor Short-term Outcomes After Major Liver Resection for Hilar Cholangiocarcinoma. By the HC-AFC-2009 Group

Abstract

Introduction: As mortality and morbidity after a curative resection remains high, it is essential to identify pre-operative factors associated with an early death after a major resection.

Methods: Between 1998 and 2008, we selected a population of 331 patients having undergone a major hepatectomy including segment I with a lymphadenectomy and a common bile duct resection for a proven hilar cholangiocarcinoma in 21 tertiary centres. The study's objective was to identify pre-operative predictors of early death (<12 months) after a resection.

Results: The study cohort consisted of 221 men and 110 women, with a median age of 61 years (range: 24-85). The post-operative mortality and morbidity rates were 8.2% and 61%, respectively. The 1-, 3- and 5-year overall survival rates were 85%, 64% and 53%, respectively. The median tumour size was 23 mm on pathology, ranging from 8 to 40. A tumour size >30 mm [odds ratio (OR) 2.471 (95% confidence interval (CI) 1.136-7.339), P = 0.001] and major post-operative complication [OR 3.369 (95% CI 1.038-10.938), P = 0.004] were independently associated with death <12 months in a multivariate analysis.

Conclusion: The present analysis of a series of 331 patients with hilar cholangiocarcinoma showed that tumour size >30 mm was independently associated with death <12 months.

Citing Articles

Prognostic influence for hilar cholangiocarcinoma and comparisons of prognostic values of Mayo staging and TNM staging systems.

Sun Z, Guo J, Li X, Wang Q, Su N, Chen M Medicine (Baltimore). 2023; 101(49):e32250.

PMID: 36626512 PMC: 9750704. DOI: 10.1097/MD.0000000000032250.


Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001).

Schmelzle M, Benzing C, Fischer L, Herden U, Sterneck M, Settmacher U Front Oncol. 2022; 12:910871.

PMID: 36330499 PMC: 9624225. DOI: 10.3389/fonc.2022.910871.


Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study.

Yu Z, Liu Q, Liao H, Shi J, Zhou Z, Yan Y J Gastrointest Oncol. 2022; 13(2):833-846.

PMID: 35557567 PMC: 9086037. DOI: 10.21037/jgo-21-543.


Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study.

Liu Z, Chen W, Wang Z, Liu X, Fan H, Xu L Front Oncol. 2022; 12:849053.

PMID: 35530316 PMC: 9071302. DOI: 10.3389/fonc.2022.849053.


Systematic review of perioperative and oncologic outcomes of minimally-invasive surgery for hilar cholangiocarcinoma.

Cipriani F, Ratti F, Fiorentini G, Reineke R, Aldrighetti L Updates Surg. 2021; 73(2):359-377.

PMID: 33615423 DOI: 10.1007/s13304-021-01006-6.


References
1.
Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T . Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004; 240(1):95-101. PMC: 1356380. DOI: 10.1097/01.sla.0000129491.43855.6b. View

2.
DeOliveira M, Schulick R, Nimura Y, Rosen C, Gores G, Neuhaus P . New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011; 53(4):1363-71. DOI: 10.1002/hep.24227. View

3.
Chatelain D, Farges O, Fuks D, Trouillet N, Pruvot F, Regimbeau J . Assessment of pathology reports on hilar cholangiocarcinoma: the results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group. J Hepatol. 2012; 56(5):1121-1128. DOI: 10.1016/j.jhep.2011.12.010. View

4.
Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G . Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg. 2012; 147(1):26-34. DOI: 10.1001/archsurg.2011.771. View

5.
Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H . Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann Surg. 2010; 251(2):281-6. DOI: 10.1097/SLA.0b013e3181be0085. View